Rosetta Genomics Ltd. (ROSGQ)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0002 (19,900.00%)
At close: Jan 7, 2026

Rosetta Genomics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Net Income
-13.39-16.23-17.35-14.53-12.9-10.46
Depreciation & Amortization
0.240.270.30.30.30.27
Other Amortization
0.570.570.56--1.55
Loss (Gain) From Sale of Assets
------0.02
Stock-Based Compensation
0.80.861.020.940.890.55
Other Operating Activities
-1.75-0.010.9-0.08-0.320.37
Change in Accounts Receivable
-0.150.01-0.01-0.11-0.14-0.08
Change in Accounts Payable
0.410.250.06-0.340.150.17
Change in Unearned Revenue
----0.23--
Change in Other Net Operating Assets
-0.782.32-1.770.450.78-1.03
Operating Cash Flow
-11.68-10.6-16.93-13.6-10.61-8.64
Capital Expenditures
-0.04-0.11-0.12-0.25-0.63-0.27
Sale of Property, Plant & Equipment
-----0.06
Cash Acquisitions
---2.12---
Investment in Securities
00.57.15-0.01-7.53-0.02
Other Investing Activities
0.920.66-0.78--0
Investing Cash Flow
0.881.054.13-0.26-8.15-0.23
Short-Term Debt Issued
-----1.75
Long-Term Debt Issued
-3.71----
Total Debt Issued
53.71---1.75
Short-Term Debt Repaid
------1.45
Long-Term Debt Repaid
--0.03----0.03
Total Debt Repaid
-0.06-0.03----1.48
Net Debt Issued (Repaid)
4.943.68---0.27
Issuance of Common Stock
--17.325.024.7438.65
Other Financing Activities
-0.42-0.42----
Financing Cash Flow
4.523.2617.325.024.7438.93
Net Cash Flow
-6.29-6.284.52-8.85-14.0230.06
Free Cash Flow
-11.73-10.7-17.05-13.85-11.23-8.91
Free Cash Flow Margin
-410.21%-524.96%-593.04%-1043.63%-2773.83%-4431.34%
Free Cash Flow Per Share
-5.61-5.81-13.56-14.79-14.05-24.03
Cash Interest Paid
-----0.29
Levered Free Cash Flow
-6.04-2.89-13.14-7.93-6.85-5.23
Unlevered Free Cash Flow
-6.18-3.09-13.33-7.9-6.84-5.63
Change in Working Capital
-0.522.58-1.72-0.240.8-0.93
Source: S&P Global Market Intelligence. Standard template. Financial Sources.